Brinkmann; Kay

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brinkmann; Kay.The latest application filed is for "pr13.5 promoter for robust t-cell and antibody responses".

Company Profile

0.9.6

Brinkmann; Kay - Munich DE
Brinkmann; Kay - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
PR13.5 promoter for robust T-cell and antibody responses Grant 11,028,130 - Steigerwald , et al. June 8, 2	2021-06-08
Poxviral vectors for low antibody response after a first priming immunization Grant 10,111,946 - Steigerwald , et al. October 30, 2	2018-10-30
Pr13.5 Promoter For Robust T-cell And Antibody Responses App 20180111966 - Steigerwald; Robin ; et al.	2018-04-26
Pr13.5 promoter for robust T-cell and antibody responses Grant 9,828,414 - Steigerwald , et al. November 28, 2	2017-11-28
Pr13.5 Promoter For Robust T-cell And Antibody Responses App 20150299267 - Steigerwald; Robin ; et al.	2015-10-22
Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements Grant 9,163,237 - Hausmann , et al. October 20, 2	2015-10-20
Poxviral Vectors For Low Antibody Response After A First Priming Immunization App 20150174238 - Steigerwald; Robin ; et al.	2015-06-25
Replication Deficient Recombinant Viruses Expressing Antigens Regulated By Transcriptional Control Elements Comprising Multiple Elements App 20140113368 - HAUSMANN; Jurgen ; et al.	2014-04-24
Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements Grant 8,613,936 - Hausmann , et al. December 24, 2	2013-12-24
Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccines Grant 8,394,385 - Hausmann , et al. March 12, 2	2013-03-12
Replication Deficient Recombinant Viruses Expressing Antigens Regulated By Transcriptional Control Elements Comprising Multiple Elements App 20120014988 - Hausmann; Jurgen ; et al.	2012-01-19
Optimized Early-late Promoter Combined With Repeated Vaccination Favors Cytotoxic T Cell Response Against Recombinant Antigen In Mva Vaccines App 20100233203 - HAUSMANN; JURGEN ; et al.	2010-09-16
Obtainment of .gamma.-linolenic acid from protozoa of the genus colpidium Grant 6,403,345 - Kiy , et al. June 11, 2	2002-06-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.